AlphaMadera combines institutional-grade analytics, real-time market data, and AI research tools to help investors make smarter long-term decisions.
Explore the Platform →Built for investors who think in decades, not days.
To our valued customers, log in here >
US stock benchmarks are stuck due to recent heightened uncertainty regarding the US-Iran ceasefire. Stock bulls remain in control with indexes remaining range-bound despite back-and-forth action in crude oil.
Central bankers must be prepared to tighten monetary policy to avoid an inflationary spiral if war-driven energy price shocks are sustained, but also need to watch for a softening of demand that would argue against rate hikes, International Monetary Fund Managing Director Kristalina Georgieva said on Thursday.
The latest Middle East conflict and energy shock are posing downside risks to global activity and upside risks to global inflation. Although the U.S. economy still displays solid macro foundations, tightening financial conditions are likely to create challenges across the economy.
The Investment Committee debate the fragile ceasefire in the Middle East and what it means for the market and your money. They share their strategies for the weeks ahead.
IMF managing director Kristalina Georgieva joins 'Money Movers' to discuss the Iran war's impact to the global economy, inflation, and more.
U.S. stocks held modest midday gains Thursday as tentative Lebanon–Israel diplomatic overtures introduced a fragile layer of optimism into an otherwise tense geopolitical backdrop.
While institutional investors drove Wednesday's rally, retail investors took it as an opportunity to cash out.
Key Takeaways:
GAAP Earnings are a flawed metric because of the numerous accounting rule loopholes that open the door for legal earnings manipulation.
India is fleshing out the Gujarat International Financial Tec-City's regulatory infrastructure, including fund management, payments and accounting and taxation.
Jeremy Siegel thinks stocks may experience more turbulence ahead, despite the major averages posting sharp gains on Wednesday. “I don't think the short term looks all that favorable to me,” Siegel, professor emeritus at University of Pennsylvania's Wharton School of Business, told CNBC on Thursday.
"This market has started to look very casino-like," says @CharlesSchwab's Liz Ann Sonders, making the case that "whipsaw" market moves are here to stay. She explains how short-term traders in equities and commodities have a significant hold of the driver's seat on Wall Street.
The recent drop of the S&P 500 does not represent a buying opportunity, as downside risk has increased further in recent months. There is a high probability of a deeper market correction in 2026, driven by deteriorating financial conditions and consumer headwinds.
I see the current "cease-fire" around the Strait of Hormuz as a temporary, ambiguous arrangement, not a true resolution or investment catalyst. Persistent operational uncertainty at Hormuz, unresolved Lebanon tensions, and shifting U.S. strategy drive ongoing volatility in energy markets and risk assets.
The war with Iran will have a lingering economic fallout.
March CPI is expected to show the inflationary hit from higher oil prices, but investors will be watching whether price pressures are spreading beyond energy.
Still-high oil prices have investors wondering which areas could help keep the market moving higher after Wednesday's rally.
Stocks that pay generous dividends should help investors stay calm—no matter what the world throws at them this year.
February's wholesale inventories print came in better than expected while GDP and core PCE fell slightly below Wall Street estimates. Kevin Green breaks down the slew of delayed economic data and how it all plays into expectations for Friday's CPI.
A close look at valuations for the largest U.S. banks highlights opportunities for long-term investors.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Colony Bankcorp (CBAN) have what it takes?
New York, New York--(Newsfile Corp. - April 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alight, Inc. (NYSE: ALIT) between November 12, 2024 and February 18, 2026, both dates inclusive (the "Class Period"), of the important May 15, 2026 lead plaintiff deadline. SO WHAT: If you purchased Alight common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
New York, New York--(Newsfile Corp. - April 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Apollo Global Management, Inc. (NYSE: APO) between May 10, 2021 and February 21, 2026, both dates inclusive (the "Class Period"), of the important May 1, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Apollo Global securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
New York, New York--(Newsfile Corp. - April 9, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Driven Brands Holdings Inc. (NASDAQ: DRVN) between May 9, 2023 and February 24, 2026, both dates inclusive (the "Class Period"), of the important May 8, 2026 lead plaintiff deadline. SO WHAT: If you purchased Driven Brands common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
Byrna Technologies Inc. (BYRN) Q1 2026 Earnings Call Transcript
Esperion Therapeutics (ESPR) reported earnings 30 days ago. What's next for the stock?
First Majestic's First Mint unit surges with record revenues and rising silver prices, boosting sales volumes and expanding its role in overall production growth.
Neogen Corporation (NEOG) Q3 2026 Earnings Call Transcript
NEW ORLEANS, April 09, 2026 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until May 26, 2026 to file lead plaintiff applications in a securities class action lawsuit against ImmunityBio, Inc. (NasdaqGS: IBRX) (“ImmunityBio” or the “Company”), if they purchased or otherwise acquired the Company's securities between January 19, 2026 and March 24, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Central District of California.
Anterix Inc. (ATEX) Discusses FCC 900 MHz Spectrum Expansion and Its Impact on Broadband Connectivity Transcript